About the role
Overview
Who We Are
Dendreon is pioneering the future of immunotherapy. For over a decade, we have harnessed the power of the patient’s own immune system to fight cancer. Our flagship cellular therapy and growing pipeline are grounded in a simple belief: the immune system holds the key to transforming cancer care.
Headquartered in Seal Beach, California, with major operations in Union City, GA and Seattle, WA, we are now expanding our impact through contract manufacturing, patient operations, and commercial excellence in cellular immunotherapies. We are a purpose-driven organization that puts patients first and raises the bar every day.
The Opportunity
We are seeking a Associate Director, Market Access & Reimbursement to lead strategy and execution for optimal patient access, reimbursement, and commercial success of our innovative oncology therapies. This critical leadership role will shape how payers, providers, GPO’s, distributors, and patients experience Dendreon’s products across all sites of care.
Responsibilities
Key Responsibilities
Align with leadership in Commercial department to develop and execute comprehensive market access and reimbursement strategies to secure favorable coverage, coding, and payment for Dendreon’s cellular immunotherapies.
Lead pricing, contracting, and gross-to-net activities, including payer and channel negotiations, government pricing compliance (Medicare Part B/D, Medicaid, 340B), and forecasting support.
Drive buy-and-bill and site-of-care strategies across urology, community oncology, academic centers, and hospital outpatient settings.
Oversee channel and distribution management, including relationships with specialty distributors, specialty pharmacies, GPOs, IDNs, and oncology networks.
Lead and develop the Field Reimbursement team and patient support programs (HUB services, prior authorization support, patient assistance).
Assist in leading both new hire and on-going commercial team training efforts
Partner closely with Commercial, Medical Affairs, Finance, Legal, Compliance, and Government Affairs to align market access efforts with brand strategy and product launches.
Attend national and regional conferences, using the opportunity to engage with thought leaders and important customers
Monitor reimbursement trends, resolve access barriers, and deliver insights to support business performance and patient access.
Represent Dendreon in payer and provider engagements, delivering compelling access strategies and business reviews.
Qualifications
Qualifications & Experience
Bachelor’s degree required; MBA, MPH, PharmD, or other advanced degree preferred.
10–12+ years of progressive experience in Market Access, Managed Markets, Reimbursement, or Commercial Strategy within the pharmaceutical/biotechnology industry.
5+ years of people leadership experience, including leading Field Reimbursement, Market Access, or Patient Support teams.
Strong experience with specialty pharmaceuticals, oncology, biologics, and buy-and-bill products.
Deep knowledge of Medicare Part B and Part D, payer contracting, coding/coverage strategies, and government pricing programs.
Proven track record supporting product launches and commercialization in complex reimbursement environments.
Experience managing relationships with payers, specialty distributors, specialty pharmacies, and provider networks.
Core Competencies
Strategic thinking and execution in market access & reimbursement
Strong financial and analytical acumen (pricing, contracting, GTN)
Outstanding cross-functional leadership and communication skills
Ability to thrive in a fast-paced, patient-focused environment
Travel: 30–50% (to meet with payers, providers, distributors, and field teams)
The Dendreon Way
We are guided by our core values:
Put Patients First
Act with Integrity
Build Trust
Raise the Bar
Drive Results
If you are passionate about expanding access to life-changing cancer therapies and want to join a high-performing team committed to making the battle against cancer personal, we want to hear from you.
Apply today and help shape the future of immunotherapy.
Originally posted on Himalayas